Xifei Yang Selected Research

Parkinson Disease (Parkinson's Disease)

4/2024	Tetramethylpyrazine Nitrone Promotes the Clearance of Alpha-Synuclein via Nrf2-Mediated Ubiquitin-Proteasome System Activation.
3/2024	Tetramethylpyrazine Nitrone alleviates D-galactose-induced murine skeletal muscle aging and motor deficits by activating the AMPK signaling pathway.
11/2023	Tetramethylpyrazine nitrone exerts neuroprotection via activation of PGC-1α/Nrf2 pathway in Parkinson's disease models.
9/2023	Low-dose Cu exposure enhanced α-synuclein accumulation associates with mitochondrial impairments in mice model of Parkinson's disease.
11/2017	Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B.
1/2016	Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xifei Yang Research Topics

Disease

35	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 12/2007
16	Cognitive Dysfunction 01/2023 - 01/2014
9	Mitochondrial Diseases (Mitochondrial Disease) 05/2023 - 12/2013
8	Ischemic Stroke 01/2023 - 01/2018
7	Neuroinflammatory Diseases 04/2023 - 01/2019
6	Parkinson Disease (Parkinson's Disease) 04/2024 - 01/2016
6	Memory Disorders (Memory Loss) 04/2023 - 01/2017
6	Amyloid Plaque 12/2021 - 02/2008
4	Stroke (Strokes) 03/2024 - 01/2018
4	Body Weight (Weight, Body) 01/2024 - 01/2014
4	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2023 - 01/2016
4	Neoplasms (Cancer) 08/2023 - 01/2010
3	Fibrosis (Cirrhosis) 03/2024 - 01/2021
3	Inflammation (Inflammations) 08/2023 - 04/2014
3	Hypoxia (Hypoxemia) 12/2021 - 08/2012
3	Infections 10/2021 - 06/2016
3	Dermatitis 11/2015 - 11/2013
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2024 - 01/2019
2	Non-alcoholic Fatty Liver Disease 01/2024 - 08/2023
2	Disease Progression 03/2023 - 01/2021
2	Nervous System Diseases (Neurological Disorders) 10/2022 - 01/2021
2	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2021 - 01/2019
2	Pathologic Processes 01/2020 - 11/2017
2	Brain Injuries (Brain Injury) 01/2019 - 01/2019
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019 - 11/2018
2	Neuroblastoma 01/2018 - 08/2014
2	Brain Ischemia (Cerebral Ischemia) 01/2018 - 12/2013
2	Autoimmune Diseases (Autoimmune Disease) 08/2014 - 11/2013
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2013 - 10/2012
1	Brain Diseases (Brain Disorder) 03/2024
1	Hyperlipidemias (Hyperlipidemia) 01/2024
1	Insulin Resistance 01/2024
1	Poisoning 09/2023
1	Fatty Liver 08/2023
1	Sleep Deprivation 06/2023
1	Sarcopenia 05/2023
1	Brain Edema (Cerebral Edema) 05/2023

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 08/2023 - 01/2010
12	Biomarkers (Surrogate Marker)IBA 06/2023 - 01/2012
10	Amyloid (Amyloid Fibrils)IBA 11/2021 - 05/2010
7	CopperIBA 09/2023 - 01/2015
6	Amyloid beta-PeptidesIBA 01/2023 - 02/2008
6	Neuroprotective AgentsIBA 01/2023 - 01/2018
5	tetramethylpyrazine nitroneIBA 03/2024 - 01/2018
5	MelatoninIBA 06/2023 - 07/2017
4	Adenosine Triphosphate (ATP)IBA 03/2024 - 01/2020
4	tetramethylpyrazineIBA 03/2024 - 01/2018
4	coenzyme Q10 (CoQ10)IBA 01/2017 - 05/2010
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 08/2012
3	Therapeutic UsesIBA 01/2023 - 01/2018
3	Presenilin-1IBA 11/2021 - 05/2010
3	ProteomeIBA 07/2021 - 06/2019
3	Memantine (Namenda)FDA Link 01/2021 - 01/2019
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 01/2019
3	N-Methylaspartate (NMDA)IBA 01/2021 - 01/2019
3	AntioxidantsIBA 01/2019 - 01/2014
3	Trichloroethylene (Trichloroethene)IBA 11/2015 - 11/2013
2	SynucleinsIBA 04/2024 - 09/2023
2	Galactose (Galactopyranose)FDA LinkGeneric 03/2024 - 04/2023
2	Thymidine Monophosphate (TMP)IBA 03/2024 - 01/2021
2	chrysinIBA 01/2024 - 08/2023
2	LipidsIBA 01/2024 - 08/2023
2	MicroRNAs (MicroRNA)IBA 05/2023 - 08/2019
2	Superoxide Dismutase-1IBA 03/2023 - 01/2019
2	Free RadicalsIBA 01/2023 - 01/2018
2	PyrrolesIBA 10/2022 - 01/2020
2	xanthohumolIBA 02/2022 - 01/2018
2	Caspase 3 (Caspase-3)IBA 01/2022 - 12/2013
2	Peptides (Polypeptides)IBA 12/2021 - 10/2015
2	tau Proteins (tau Protein)IBA 12/2021 - 01/2020
2	Indicators and Reagents (Reagents)IBA 07/2021 - 01/2014
2	NitratesIBA 01/2021 - 01/2019
2	Apolipoprotein E4IBA 01/2021 - 01/2019
2	1,2,3,4-tetrahydroisoquinolineIBA 01/2020 - 01/2018
2	AlkaloidsIBA 01/2020 - 01/2018
2	dauricineIBA 01/2020 - 01/2018
2	Glutamic Acid (Glutamate)FDA Link 01/2019 - 01/2019
2	HomocysteineIBA 01/2019 - 12/2007
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2018 - 10/2015
2	CalciumIBA 01/2018 - 08/2012
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 12/2013 - 08/2012
2	Inosine Triphosphate (ITP)IBA 10/2013 - 10/2012
2	GlucocorticoidsIBA 10/2013 - 10/2012
1	Hematoxylin (Haematoxylon)IBA 03/2024
1	Matrix Metalloproteinases (MMPs)IBA 03/2024
1	Eosine Yellowish-(YS) (Eosin)IBA 03/2024
1	FlavonoidsIBA 01/2024
1	ProdrugsIBA 01/2024
1	arctigeninIBA 12/2023
1	Drinking WaterIBA 09/2023
1	InflammasomesIBA 08/2023
1	C-Reactive ProteinIBA 06/2023
1	MyoglobinIBA 05/2023
1	Aquaporin 4IBA 05/2023
1	Circular RNAIBA 05/2023
1	CytokinesIBA 04/2023

Therapy/Procedure

5	Therapeutics 01/2024 - 10/2012
2	Oral Administration 01/2024 - 05/2010
2	Immunotherapy 10/2021 - 10/2020
1	Precision Medicine 08/2023